APA (7th ed.) Citation

Li, R., Qin, Q., Yang, H., Wang, Y., Mi, Y., Yin, Y., . . . Tang, Y. (2022). TREM2 in the pathogenesis of AD: A lipid metabolism regulator and potential metabolic therapeutic target. Molecular neurodegeneration, 17(1), 40-19. https://doi.org/10.1186/s13024-022-00542-y

Chicago Style (17th ed.) Citation

Li, Rui-Yang, Qi Qin, Han-Chen Yang, Ying-Ying Wang, Ying-Xin Mi, Yun-Si Yin, Meng Wang, Chao-Ji Yu, and Yi Tang. "TREM2 in the Pathogenesis of AD: A Lipid Metabolism Regulator and Potential Metabolic Therapeutic Target." Molecular Neurodegeneration 17, no. 1 (2022): 40-19. https://doi.org/10.1186/s13024-022-00542-y.

MLA (9th ed.) Citation

Li, Rui-Yang, et al. "TREM2 in the Pathogenesis of AD: A Lipid Metabolism Regulator and Potential Metabolic Therapeutic Target." Molecular Neurodegeneration, vol. 17, no. 1, 2022, pp. 40-19, https://doi.org/10.1186/s13024-022-00542-y.